ClearPoint Neuro Announces FDA De Novo Marketing Authorization of SmartFlow Cannula for Direct Delivery of Gene Therapy to the Brain
Modifying Treatment for AADC Deficiency in the United States SOLANA BEACH, CA / / November 13, 2024 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the 'Company'), a global therapy-enabling platform company ...
Le Lézard12h
Subtle Medical Unveils Subtle-ELITE and New Strategic Partnerships at RSNA 2024
Offering new tools like Magnetic Mask and the highly anticipated... PTC Therapeutics, Inc. announced today the U.S. Food and Drug Administration (FDA) accelerated approval of its gene therapy for the ...
Seeking Alpha11h
Zoom Video ticks up as Morgan Stanley ups target ahead of Q3 results
Zoom Video (NASDAQ:ZM) shares rose fractionally in premarket trading on Wednesday as Morgan Stanley upped its price target on ...
manilatimes13h
Plug Power Hosts 2024 Plug Symposium
Plug targets ~30% CAGR for Energy and Applications businesses from 2025 to 2030 and appoints Sanjay Shrestha new President ...
Le Lézard7h
Geo Week Announces 2025 Conference Program and Speakers
Offering new tools like Magnetic Mask and the highly anticipated... at 18:02 PTC Therapeutics Announces FDA Approval of AADC Deficiency Gene Therapy PTC Therapeutics, Inc. announced today the U.S.